A U.S. gestational carrier reportedly learned mid-pregnancy that the intended father was Chinese billionaire Xu Bo, who is alleged to have fathered more than 300 children born in the United States through a coordinated surrogacy network. The surrogate says she was not informed of the scale of Xu Bo's reproduction plans before she agreed to carry. The case has drawn coverage from The Indian Express, Times of India, and Hindustan Times, all reporting on what appears to be a deliberate scheme to obtain U.S. birthright citizenship for a large number of children.
This is the story that will define the week. It illustrates precisely what unregulated matching can look like at its extreme: a carrier who consented to one arrangement and found herself in a very different one. Before signing with any agency or independent matching service, ask for full disclosure of the intended parent's identity and reproductive history.
A multi-part CBS News investigation published September 13 spoke with surrogates who described gaps in screening, contract enforcement, and post-birth support. One report focused on the question of who legally receives a baby when an arrangement breaks down, highlighting that state-by-state variation leaves both carriers and intended parents exposed. A companion CBS piece examined the broader ethical questions these practices raise.
CBS putting this much editorial weight behind one investigation signals that mainstream scrutiny of the industry is intensifying. Whether or not federal legislation follows, the spotlight alone tends to prompt agencies to tighten their processes. If you are mid-journey, this is a good moment to re-read your contract with fresh eyes.
The Guardian reports that the surrogate at the center of the McKenna West case has now formally appealed to the Supreme Court after fleeing to Texas with the baby. This follows the biological parents' pushback on an earlier Supreme Court petition covered in our September 12 brief.
Worth watching closely. The Supreme Court's willingness, or refusal, to hear this case will set the tone for how custody conflicts in cross-state surrogacy arrangements are handled for years to come.
USA Today profiled an intended parent whose state did not recognize her as her daughter's legal mother for two years following the surrogacy birth. The story details the administrative and emotional toll of that gap, including school enrollment complications and a medical consent scare. The piece is part of broader national coverage examining how state parentage laws lag behind the reality of how families are being formed.
Your attorney should file for a pre-birth or post-birth parentage order well before your due date. This story is a reminder of what happens when that step is skipped or delayed, and the consequences are not just paperwork.
The Luxembourg Times profiled a single father who, unable to access surrogacy domestically due to legal restrictions, is exploring arrangements in countries where it is permitted. His experience mirrors that of many European intended parents navigating a patchwork of national laws with no clear regional framework in place. The piece adds a personal dimension to a structural gap that the UK Parliament debate has also been circling.
This one is quietly important. The UK, Luxembourg, and much of Western Europe are producing intended parents who must go abroad while their home countries debate whether to act. The gap between demand and legal access is not closing.
The Xu Bo story and the CBS investigation arrived on the same news cycle, and that is not a coincidence in terms of what it signals. Both stories center on the same structural problem: in the absence of federal standards, the U.S. surrogacy industry relies almost entirely on private contracts and agency self-regulation to protect carriers and intended parents alike. When those private systems fail, or are deliberately exploited, there is no floor.
Know ThisHow Intended Parents Finance a Surrogacy Journey
Surrogacy is one of the most meaningful investments a family can make, and understanding your financing options early can reduce stress and help you plan with confidence. Most intended parents draw from more than one source to cover costs that typically range from $100,000 to $180,000 in the United States.
Personal savings are the most straightforward path and the most widely used. If you have home equity, a Home Equity Line of Credit (HELOC) is another accessible option — interest rates are generally lower than personal loans, and the funds can be drawn as needed throughout the journey. Some families also turn to retirement accounts, though early withdrawal penalties make this a last resort worth discussing with a financial advisor first.
Fertility-specific financing programs, offered by lenders like CapexMD and Future Family, are designed specifically for family-building costs and can be a practical bridge when savings fall short. These are broadly available but come with interest, so comparing terms carefully matters. If you work for a larger employer, it is worth reviewing your benefits package closely — many Fortune 500 companies now cover surrogacy costs up to a set amount, and Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs) can offset some medical expenses for the intended mother or surrogate depending on your plan's rules.
Grants through nonprofit organizations like BabyQuest Foundation and Men Having Babies offer meaningful financial relief, but competition is real — these awards are limited and application cycles happen once or twice a year, so applying early and thoroughly is essential.
On the tax side, the landscape remains limited. Some medical expenses may be partially deductible if they exceed the IRS threshold, but surrogacy-specific costs are rarely fully deductible. A tax professional with fertility experience can help you identify every legitimate deduction available to you.
Get this brief in your inbox every morning.
One email, the stories that matter for your journey, explained.